<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">445807210</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180317145200.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170323e20110101xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/s00415-010-5674-5</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/s00415-010-5674-5</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Afferent facilitation of corticomotor responses is increased by IgGs of patients with NMDA-receptor antibodies</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[Mario Manto, Josep Dalmau, Adrien Didelot, Véronique Rogemond, Jérôme Honnorat]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">A severe subacute encephalitis associated with auto-antibodies to the NMDA receptor (NMDA-R) has been reported in humans. These antibodies are directed to NR1/NR2 heteromers of the NMDA receptor. We studied the effects of patients' cerebrospinal fluid (CSF) injected in rFr2 (the prefrontal area) on the afferent facilitation in a conditioning paradigm for corticomotor responses. The afferent facilitation was assessed in forelimbs and hindlimbs of rats, before and after application of trains of high-frequency stimulation (HFS) which are known to modulate the excitability of M1. Before HFS, patients' CSF did not modify afferent facilitation. After HFS, the amplitudes of corticomotor responses before conditioning were significantly larger in forelimbs and hindlimbs. There was an increase of the afferent facilitation in forelimbs. The same effect was observed after injection of purified IgGs from patients' sera. Our results highlight that IgGs of patients with NMDA-R antibodies induce a state of corticomotor hyperexcitability following application of HFS over the prefrontal area.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Springer-Verlag, 2010</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Antibodies</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">NMDA receptor</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Encephalitis</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Afferent facilitation</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Conditioning</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Manto</subfield>
   <subfield code="D">Mario</subfield>
   <subfield code="u">FNRS Neurologie ULB, Laboratoire de Neurologie Expérimentale, 808 Route de Lennik, 1070, Bruxelles, Belgium</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Dalmau</subfield>
   <subfield code="D">Josep</subfield>
   <subfield code="u">Division of Neuro-oncology, Department of Neurology, University of Pennsylvania, 3400 Spruce Street, Philadelphia, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Didelot</subfield>
   <subfield code="D">Adrien</subfield>
   <subfield code="u">Hospices Civils de Lyon, Hôpital Neurologique, Centre de Référence Maladie Rare &quot;Syndromes neurologiques Paranéoplasiques”, Neurologie B, 69677, Bron, France</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Rogemond</subfield>
   <subfield code="D">Véronique</subfield>
   <subfield code="u">Hospices Civils de Lyon, Hôpital Neurologique, Centre de Référence Maladie Rare &quot;Syndromes neurologiques Paranéoplasiques”, Neurologie B, 69677, Bron, France</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Honnorat</subfield>
   <subfield code="D">Jérôme</subfield>
   <subfield code="u">Hospices Civils de Lyon, Hôpital Neurologique, Centre de Référence Maladie Rare &quot;Syndromes neurologiques Paranéoplasiques”, Neurologie B, 69677, Bron, France</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Journal of Neurology</subfield>
   <subfield code="d">Springer-Verlag</subfield>
   <subfield code="g">258/1(2011-01-01), 27-33</subfield>
   <subfield code="x">0340-5354</subfield>
   <subfield code="q">258:1&lt;27</subfield>
   <subfield code="1">2011</subfield>
   <subfield code="2">258</subfield>
   <subfield code="o">415</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/s00415-010-5674-5</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/s00415-010-5674-5</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Manto</subfield>
   <subfield code="D">Mario</subfield>
   <subfield code="u">FNRS Neurologie ULB, Laboratoire de Neurologie Expérimentale, 808 Route de Lennik, 1070, Bruxelles, Belgium</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Dalmau</subfield>
   <subfield code="D">Josep</subfield>
   <subfield code="u">Division of Neuro-oncology, Department of Neurology, University of Pennsylvania, 3400 Spruce Street, Philadelphia, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Didelot</subfield>
   <subfield code="D">Adrien</subfield>
   <subfield code="u">Hospices Civils de Lyon, Hôpital Neurologique, Centre de Référence Maladie Rare &quot;Syndromes neurologiques Paranéoplasiques”, Neurologie B, 69677, Bron, France</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Rogemond</subfield>
   <subfield code="D">Véronique</subfield>
   <subfield code="u">Hospices Civils de Lyon, Hôpital Neurologique, Centre de Référence Maladie Rare &quot;Syndromes neurologiques Paranéoplasiques”, Neurologie B, 69677, Bron, France</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Honnorat</subfield>
   <subfield code="D">Jérôme</subfield>
   <subfield code="u">Hospices Civils de Lyon, Hôpital Neurologique, Centre de Référence Maladie Rare &quot;Syndromes neurologiques Paranéoplasiques”, Neurologie B, 69677, Bron, France</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Journal of Neurology</subfield>
   <subfield code="d">Springer-Verlag</subfield>
   <subfield code="g">258/1(2011-01-01), 27-33</subfield>
   <subfield code="x">0340-5354</subfield>
   <subfield code="q">258:1&lt;27</subfield>
   <subfield code="1">2011</subfield>
   <subfield code="2">258</subfield>
   <subfield code="o">415</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
